Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-19-000167
Filing Date
2019-02-28
Accepted
2019-02-28 17:25:56
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCORBIMED ROF II LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss127588_sc13d.htm SC 13D 167706
2 JOINT FILING AGREEMENT ss127588_ex9901.htm EX-99.1 21396
  Complete submission text file 0000947871-19-000167.txt   190597
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 201 JONES ROAD WALTHAM MA 02451
Business Address 201 JONES ROAD WALTHAM MA 02451 781 768 3400
AVEDRO INC (Subject) CIK: 0001343304 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90939 | Film No.: 19645053
SIC: 2834 Pharmaceutical Preparations